Demonstrates thymosin β4 protects human umbilical vein endothelial cells from advanced glycation end product (AGE) toxicity by remodeling the actin cytoskeleton. AGEs increased RAGE receptor expression and the F-actin/G-actin ratio—indicators of cytoskeletal damage—while impairing angiogenic tube formation. TB4 reversed all these effects by downregulating RAGE and restoring actin equilibrium. Establishes a TB4→actin remodeling→RAGE suppression mechanism for protecting the vasculature from glycation-induced endothelial toxicity—relevant to the vascular complications of diabetes where AGE accumulation drives endothelial dysfunction.
Kim, Sokho; Kwon, Jungkee